Medicamen Biotech Ltd.
BSE: 531146 | Sector: Health care |
NSE: MEDICAMEQ | ISIN Code: INE646B01010 |
BSE 00:00 | 23 Mar | 620.20 |
-23.15 (-3.60%) |
OPEN
639.50 |
HIGH
650.95 |
LOW
617.90 |
NSE 00:00 | 23 Mar | 622.10 |
-23.60 (-3.65%) |
OPEN
645.70 |
HIGH
654.50 |
LOW
618.00 |
OPEN | 639.50 |
PREVIOUS CLOSE | 643.35 |
VOLUME | 812 |
52-Week high | 1219.00 |
52-Week low | 558.80 |
P/E | 57.21 |
Mkt Cap.(Rs cr) | 785 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Medicamen Biotech Ltd. (MEDICAMEQ) - Financial Ratios
Ratios | 2022 | 2021 | 2020 |
Debt-Equity Ratio | 0.16 | 0.12 | 0.11 |
Current Ratio | 1.76 | 1.87 | 1.94 |
Asset turnover ratio | 0.96 | 1.27 | 2.25 |
Inventory turnover ratio | 7.17 | 9.94 | 7.28 |
Debtors turnover ratio | 2.08 | 2.35 | 2.69 |
Interest Coverage ratio | 10.34 | 12.09 | 18.85 |
Operating Margin (%) | 22.36 | 18.87 | 17.07 |
Net Profit Margin (%) | 12.91 | 11.34 | 10.45 |
Return on Capital Employed (%) | 12.17 | 12.62 | 14.96 |
Return on Net Worth (%) | 10.56 | 9.73 | 11.73 |
Quick Links for Medicamen Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices